Skip to search formSkip to main contentSkip to account menu

BIIL 284

Known as: BIIL 284 BS, BIIL-284, BIIL-284 BS 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
2013
2013
Insufficient oxygen delivery to organs leads to tissue dysfunction and cell death. Reperfusion, although vital to organ survival… 
2007
2007
Background: Several clinical and experimental lines of evidence suggest that leucotriene B4 (LTB4), an arachidonic acid… 
2007
2007
  • Nature Clinical Practice Rheumatology
  • 2007
  • Corpus ID: 34772172
A multicenter, randomized, double-blind trial has failed to demonstrate efficacy of BIIL 284— a leukotriene B4 (LTB4) receptor… 
Highly Cited
2005
Highly Cited
2005
Leukotriene B(4) (LTB(4)), a potent leukocyte chemoattractant derived from the 5-lipoxygenase metabolism of arachidonic acid… 
2004
2004
Background: Leukotriene B4 (LTB4) has a key role in the pathophysiology of rheumatoid arthritis (RA). Objective: To investigate… 
Highly Cited
2001
Highly Cited
2001
BIIL 284 is a new LTB(4) receptor antagonist. It is a prodrug and has negligible binding to the LTB(4) receptor. However…